OBJECTIVE: To investigate clinicopathologic factors influencing the serum of IL-12 level of @entity1 with PHC. METHOD: Serum interleukin-12 (IL-12) level was determined by ELISA in 16 @entity1 with primary @entity96 (PHC). The following clinicopathologic factors were considered for the serum IL-12 effect: age, serum albumin and serum total @entity648 , size of @entity5 , number of @entity5 , @entity5 thrombus of portal vessels (present or absent), time of operation, @entity5 resected (yes or no), histological grade of @entity5 , and the amount of lost blood during operation. Dependent variables were serum IL-12 level at 1 day before operation and at 1 and 7 days after operation. The multivariate results were confirmed using multiple regression analysis. RESULT: Size of @entity5 and serum albumin greatly affected serum IL-12 level before operation. Serum total @entity648 and age affected serum IL-12 level. It was significantly different before and after operation, because of the amount of lost blood. CONCLUSION: The main effective factors of serum IL-12 level were size of @entity5 and the hepatic function of @entity1 . Operative @entity130 was the major factor reducing IL-12 level after operation.

[Clinicopathologic factors influencing the serum of interleukin-12 level of XXXX with PHC: multivariate statistical analysis].

@entity1 :: ('9606', 'Species') :: ['patients'] @entity96 :: ('MESH:D008113', 'Disease') :: ['hepatic carcinoma'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor'] @entity648 :: ('MESH:D001663', 'Chemical') :: ['bilirubin'] @entity130 :: ('MESH:D014947', 'Disease') :: ['trauma']
@entity1 :: (9606,Species) :: ['patients']
